Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales153 290177 526184 765189 070197 565207 089
EBITDA11 90813 05312 65312 51412 78513 312
Operating profit (EBIT)10 42711 3739 98710 00310 16810 585
Pre-Tax Profit (EBT)------
Net income5 2375 3176 6225 7616 0696 086
P/E ratio21,116,111,312,010,710,3
EPS ( $ )4,634,906,445,446,116,30
Dividend per Share ( $ )1,401,702,002,152,362,51
Yield1,43%2,15%2,76%3,31%3,62%3,86%
Reference price ( $ )97.7778.9172.565.1265.1265.12
Announcement Date02/09/2016
11:51am
02/09/2017
11:55am
02/08/2018
11:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt24 91724 07325 19520 87319 13815 781
Finance------
Operating income (EBITDA)11 90813 05312 65312 51412 78513 312
Leverage
(Debt/EBITDA)
2,09x1,84x1,99x1,67x1,50x1,19x
Capital Expenditure2 3672 2241 9182 2232 1942 491
Book Value Per Share (BVPS)33,8 $34,7 $37,1 $40,7 $42,0 $44,2 $
Cash Flow per Share7,47 $9,33 $7,82 $8,54 $8,62 $9,24 $
Announcement Date02/09/2016
11:51am
02/09/2017
11:55am
02/08/2018
11:55am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 66 066 M$ -
Entreprise Value (EV) 86 939 M$ 85 204 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 12,0x 10,7x
Capitalization / Revenue 0,35x 0,33x
EV / Revenue 0,46x 0,43x
EV / EBITDA 6,95x 6,66x
Yield (DPS / Price) 3,31% 3,62%
Price to book (Price / BVPS) 1,60x 1,55x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 5,29% 5,15%
operating Leverage (Delta EBIT / Delta Sales) 0,07x 0,37x
Net Margin (Net Profit / Revenue) 3,05% 3,07%
ROA (Net Profit / Asset) 4,98% 4,15%
ROE (Net Profit / Equities) 14,5% 14,1%
Rate of Dividend 39,6% 38,6%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   1,18% 1,11%
Cash Flow / Sales 4,58% 4,42%
Capital Intensity (Assets / Sales) 0,61x 0,74x
Financial Leverage (Net Debt / EBITDA) 1,67x 1,50x
EPS & Dividend